Copyright
©2013 Baishideng. All rights reserved.
Drug-transporter interaction testing in drug discovery and development
Peter Krajcsi, Solvo Biotechnology, R and D, 2040 Budaors, Hungary
Author contributions: Krajcsi P solely contributed to this paper.
Supported by FP7 IMI MIP-DILI: Mechanism-based integrated systems for the prediction of drug-induced liver injury, FP7 Eustroke, Health-F2-2008-202213: European Stroke Research Network; TUDAS-1-2006-0029, OMFB-00505/2007: Development of HTS kit for analyzing transporter-drug interactions using cholesterol treated insect-cells expressing human MXR transporter, GOP-1.1.1-11-2011-0017: Integrated preclinical tools for the determination and the enhancement of drug absorption
Correspondence to: Peter Krajcsi, PhD, Solvo Biotechnology, R and D, 2040 Budaors, Hungary. krajcsi@solvo.com
Telephone: +36-23-503940 Fax: +36-23-503941
Received: August 21, 2012
Revised: January 8, 2013
Accepted: January 29, 2013
Published online: March 9, 2013
Processing time: 230 Days and 5.7 Hours
Revised: January 8, 2013
Accepted: January 29, 2013
Published online: March 9, 2013
Processing time: 230 Days and 5.7 Hours
Core Tip